{"id":61970,"date":"2024-02-19T13:44:03","date_gmt":"2024-02-19T13:44:03","guid":{"rendered":"https:\/\/news.pakistaninewspaperlist.com\/medigene-to-present-at-upcoming-conferences\/"},"modified":"2024-02-19T13:44:03","modified_gmt":"2024-02-19T13:44:03","slug":"medigene-to-present-at-upcoming-conferences","status":"publish","type":"post","link":"https:\/\/pakistaninewspaperlist.com\/news\/medigene-to-present-at-upcoming-conferences\/","title":{"rendered":"Medigene to Present at Upcoming Conferences"},"content":{"rendered":"<div id=\"main-body-container\" itemprop=\"articleBody\">\n<p align=\"justify\"><b>Planegg\/Martinsried, February 19, 2024.<\/b> <u>Medigene AG<\/u> (Medigene or the \u201cCompany\u201d, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will present at the 7<sup>th<\/sup> CAR-TCR Summit Europe taking place February 27-29, 2024, in London as well as at the East-West Biopharma Summit to be held March 4-6, 2024, in Singapore. <\/p>\n<p align=\"justify\"><b>7<sup>th<\/sup> CAR-TCR Summit Europe 2024<\/b><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4_E1sBO3P6uWaiBzBzvg3PB-c581f75RwCoaBLSQNx-utMgR9YyH-AcuPVBEitkrdhpHXCjV3uKEe7Tus4zzZDly_q2HRnhLDwYj_Nz_OYg=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>https:\/\/cartcr-europe.com\/<\/u><\/a><\/p>\n<p align=\"justify\"><b>Presentation<\/b><\/p>\n<p align=\"justify\">Date: February 28, 2024, 5:30 pm local time<br \/>Location: London, UK<br \/>Presenter: Prof. Dr. Dolores Schendel, CSO<br \/>Presentation: Developing effective methods to monitor, track &amp;assess T-cell efficacy in vivo &amp; in vitro<\/p>\n<p align=\"justify\"><b>Pre-conference workshop<\/b><\/p>\n<p align=\"justify\">Date: February, 27, 2024, 1 pm local time<br \/>Location: London, UK<br \/>Co-Host: Dr. Barbara L\u00f6sch, Head, Technology &amp; Innovation<br \/>Topic: Incorporating modular control into cell therapies through receptors to enhance therapy persistence &amp; safety<\/p>\n<p align=\"justify\"><b>Panel discussion<\/b><\/p>\n<p align=\"justify\">Date: February 28, 2024, 12:30 pm local time<br \/>Location: London, UK<br \/>Participant: Dr. Kirsty Crame, Vice President, Clinical Strategy &amp; Development<br \/>Panel topic: Selecting the right indications to ensure successful clinical outcomes<\/p>\n<p align=\"justify\"><b>Corporate presentation \u2013 East-West Biopharma Summit 2024<\/b><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4_E1sBO3P6uWaiBzBzvg3ES-96fGbTa1okd5gogkvXa1gkEjLy8qCTzX6naTCtj5HvwD4Pfp5yTkT5m7WkAjZOZxLmJ_8QC9Z1LtQoDdx-cnThBW86zP5agoNRcIwik_xVd8SJJyj2fDpyl7nupPA7lSUXCKunX6mvgkGUOE8gw=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>https:\/\/conferences.biocentury.com\/east-west-summit<\/u><\/a><\/p>\n<p align=\"justify\">Date: March 5, 2024<br \/>Location: \u2060\u2060Park Royal Collection \u2060Marina Bay, Singapore<br \/>Speaker: Dr. Selwyn Ho, CEO<\/p>\n<p align=\"justify\">Members of Medigene\u2019s management team will be available for one-on-one meetings at the events. Please contact Dr. Fotini Vogiatzi at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xn_Cb66RQ-gPAkXL5q44mSuyhe2x738_FGR6hWpcNfU6wghvP4Ih98NfGIlKleH4T7AuBXwKEMzNZWYtIXvjxnBBFxE-UlQA-V015Dbdagg=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"f.vogiatzi@medigene.com\">f.vogiatzi@medigene.com<\/a> to schedule a meeting at either one of the conferences.<\/p>\n<p align=\"center\"><i>&#8212;\u00a0 end of press release\u00a0 &#8212;<\/i><\/p>\n<p align=\"justify\"><b>About Medigene AG<\/b><\/p>\n<p align=\"justify\">Medigene AG (FSE: MDG1) is an immuno-oncology platform company dedicated to developing differentiated T cell therapies for treatment of solid tumors. Its End-to-End Platform is built on multiple proprietary and exclusive technologies that enable the Company to generate optimal T cell receptors against both cancer testis antigens (CTAs) and neoantigens, armor and enhance these TCR-T cells to create best-in-class, differentiated T cell receptor engineered T cell (TCR-T) therapies, and optimize the drug product composition for safety, efficacy and durability. The End-to-End Platform provides product candidates for both its in-house therapeutics pipeline and partnering. Medigene\u2019s lead TCR-T program MDG1015 is expected to receive IND\/CTA approval in the second half of 2024. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4_E1sBO3P6uWaiBzBzvg3Hp2UHjMXY00paKRGy0cW2gTXTT4Qje58ErXwhDLm0fx4Y3579RKeMseCw2TSJcJJcPdt88kg-7u1YjeLY3QxUE=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>https:\/\/medigene.com\/<\/u><\/a>.<\/p>\n<p align=\"justify\"><b>Medigene<\/b><\/p>\n<p align=\"left\">Pamela Keck<br \/>Phone: +49 89 2000 3333 01<br \/>E-mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8oLhWlb7GajZ9g9iQvHbaBgktyxe_CeWtJZhFd8HpCruivsQU93OB1SdHDJPfyuHHp_7Ni4E2ViHvDuTkosRTNuPnj_Il4KXp96WkXHJElY=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>investor@medigene.com<\/u><\/a><\/p>\n<p align=\"justify\">In case you no longer wish to receive any information about Medigene, please inform us by e-mail (<u>investor@medigene.com<\/u>). We will then delete your address from our distribution list.<\/p>\n<p>\n            <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Planegg\/Martinsried, February 19, 2024. Medigene AG (Medigene or the \u201cCompany\u201d, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will present at the 7th CAR-TCR Summit Europe taking place February 27-29, 2024, in London as well as at the East-West Biopharma Summit to [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":61971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/1464b205-f24e-4ae8-ab69-85968b38d774","fifu_image_alt":"","footnotes":""},"categories":[208],"tags":[],"class_list":["post-61970","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/61970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/comments?post=61970"}],"version-history":[{"count":0,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/61970\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media\/61971"}],"wp:attachment":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media?parent=61970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/categories?post=61970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/tags?post=61970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}